BIIB vs LULU · P/E 21, rev $9.89B vs P/E 17, rev $11.10B
Biogen Inc (BIIB) versus Lululemon Athletica Inc. (LULU) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Lululemon Athletica Inc. (LULU) is a apparel retail company listed on US. It is led by Calvin McDonald.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported LULU revenue for 2026-02-01 was $11.10B. Net income was $1.58B. LULU currently screens at market cap $29.68B and trailing P/E 16.8.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. LULU currently screens at market cap $29.68B and trailing P/E 16.8.
Not investment advice. Open the BIIB and LULU stock pages for the full models.
Not investment advice.